Progyny(PGNY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PGNY Progyny

Trading 02-02 12:02:34 EST

24.04

+0.17

+0.71%

High24.11	Low23.53	Vol398.35K
Open23.87	D1 Closing23.87	Amplitude2.43%
Mkt Cap2.07B	Tradable Cap1.91B	Total Shares86.21M
T/O9.55M	T/O Rate0.50%	Tradable Shares79.60M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"PGNY","market":"US","secType":"STK","nameCN":"Progyny","latestPrice":24.04,"timestamp":1770051741391,"preClose":23.87,"halted":0,"volume":398345,"delay":0,"changeRate":0.007121910347716721,"floatShares":79604947,"shares":86211654,"eps":0.617266,"marketStatus":"Trading","change":0.17,"latestTime":"02-02 12:02:34 EST","open":23.87,"high":24.11,"low":23.5292,"amount":9546549.04785,"amplitude":0.024332,"askPrice":24.05,"askSize":491,"bidPrice":24.04,"bidSize":252,"shortable":3,"etf":0,"ttmEps":0.617266,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1770066000000},"marketStatusCode":2,"adr":0,"listingDate":1571976000000,"exchange":"NASDAQ","adjPreClose":23.87,"preHourTrading":{"tag":"盘前","latestPrice":23.89,"preClose":23.87,"latestTime":"09:29 EST","volume":720,"amount":17165.739599999997,"timestamp":1770042599999,"change":0.02,"changeRate":0.000838,"amplitude":0.016339},"postHourTrading":{"tag":"盘后","latestPrice":23.87,"preClose":23.87,"latestTime":"18:13 EST","volume":35149,"amount":839004.28,"timestamp":1769814808923,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.712123,"impliedVol":0.6108,"impliedVolPercentile":0.6454},"requestUrl":"/m/hq/s/PGNY/wiki","defaultTab":"wiki","newsList":[{"id":"2608062090","title":"Is Progyny (PGNY) Pricing Reflect Future Growth After Recent Share Price Weakness","url":"https://stock-news.laohu8.com/highlight/detail?id=2608062090","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608062090?lang=en_us&edition=fundamental","pubTime":"2026-02-01 09:23","pubTimestamp":1769908997,"startTime":"0","endTime":"0","summary":"If you are wondering whether Progyny's current share price really reflects what the business is worth, this breakdown will help you connect the recent moves in the stock to what the numbers say about value.\nProgyny's share price closed at US$23.87, with returns of a 5.4% decline over the last 7 days, a 7.0% decline over the last 30 days, a 7.3% decline year to date, a 3.0% gain over the last year, a 32.9% decline over the last 3 years and a 52.2% decline over the last 5 years. These moves...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6034000-choice2-main-header/1585187286151","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6034000-choice2-main-header/1585187286151"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-pgny/progyny/news/is-progyny-pgny-pricing-reflect-future-growth-after-recent-s","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-pgny/progyny/news/is-progyny-pgny-pricing-reflect-future-growth-after-recent-s","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PGNY","DCF","BK4154"],"gpt_icon":0},{"id":"2605106268","title":"Progyny Inc : Btig Raises Target Price to $35 From $30","url":"https://stock-news.laohu8.com/highlight/detail?id=2605106268","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605106268?lang=en_us&edition=fundamental","pubTime":"2026-01-21 19:27","pubTimestamp":1768994828,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nFWN3YM10H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4154","PGNY"],"gpt_icon":0},{"id":"2604191426","title":"Progyny Raised to Market Outperform From Market Perform by Citizens","url":"https://stock-news.laohu8.com/highlight/detail?id=2604191426","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604191426?lang=en_us&edition=fundamental","pubTime":"2026-01-20 18:32","pubTimestamp":1768905120,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PGNY/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 20, 2026 05:32 ET (10:32 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PGNY"],"gpt_icon":0},{"id":"2604199113","title":"Progyny upgraded to Outperform from Market Perform at Citizens","url":"https://stock-news.laohu8.com/highlight/detail?id=2604199113","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604199113?lang=en_us&edition=fundamental","pubTime":"2026-01-20 17:45","pubTimestamp":1768902315,"startTime":"0","endTime":"0","summary":"Citizens analyst Constantine Davides upgraded Progyny (PGNY) to Outperform from Market Perform with a $30 price target The firm says a meeting with...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/progyny-upgraded-to-outperform-from-market-perform-at-citizens-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/progyny-upgraded-to-outperform-from-market-perform-at-citizens-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PGNY"],"gpt_icon":0},{"id":"2603636070","title":"Progyny Inc. Highlights Client Growth and Cost Management in Latest Corporate Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2603636070","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603636070?lang=en_us&edition=fundamental","pubTime":"2026-01-14 00:47","pubTimestamp":1768322835,"startTime":"0","endTime":"0","summary":"Progyny Inc. delivered a presentation at the 2026 JP Morgan Conference, highlighting significant growth metrics and operational achievements. The company reported having over 600 clients and approximately 7.6 million covered lives in 2026, representing a sevenfold and fivefold increase, respectively, since its IPO. Revenue was noted to have increased by 5.6 times, with a 33% compound annual growth rate from 2019 through 2025. Adjusted EBITDA grew at a 51% compound annual rate over the same period, and cumulative operating cash flow reached $665 million from 2019 through September 2025. The company also reported more than $1.7 million in revenue per employee. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nNDL5q3m3H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999002232.USD","LU0942090050.USD","LU0211326839.USD","IE00BZ1G4Q59.USD","LU1551013342.USD","LU0106261372.USD","LU2237443622.USD","LU0211328371.USD","LU2456880835.USD","LU0868494708.USD","IE00BDRTCR15.USD","LU0345770308.USD","LU0496365809.HKD","LU0323591593.USD","LU1162221912.USD","LU1496350171.SGD","LU1496350502.SGD","LU1894683348.USD","LU1261432733.SGD","LU2023250504.SGD","LU1267930490.SGD","LU2505996509.AUD","IE00B775SV38.USD","LU1244550494.USD","BK4207","IE00BN8TJ469.HKD","LU0070302665.USD","LU2505996681.GBP","LU0215105999.USD","LU2552382215.SGD","IE00BWXC8680.SGD","BK4516","LU1032466523.USD","LU1064131342.USD","LU2236285917.USD","LU0256863811.USD","LU0320765646.SGD","IE00BBT3K403.USD","IE0034235188.USD","PGNY","IE00BKDWB100.SGD","LU1244550577.SGD","LU0683600562.USD","LU0820562030.AUD","LU1670627923.USD","BK4588","LU1894683264.USD","LU2237443895.HKD","LU0238689110.USD","LU0203347892.USD"],"gpt_icon":0},{"id":"2602104285","title":"BRIEF-Progyny Inc Anticipates Q4 And Full Year Results To Be Slightly Above Previously Provided Financial Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2602104285","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602104285?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:14","pubTimestamp":1768223673,"startTime":"0","endTime":"0","summary":"BRIEF-Progyny Inc Anticipates Q4 And Full Year Results To Be Slightly Above Previously Provided Financial GuidanceJan 12  - Progyny Inc PGNY.O:PROGYNY INC: ANTICIPATES Q4 AND FULL YEAR RESULTS TO BE SLIGHTLY ABOVE PREVIOUSLY PROVIDED FINANCIAL GUIDANCESource text: [ID:n0001551306-26-000009]Further company coverage: PGNY.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nFWN3YD169:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PGNY","BK4154"],"gpt_icon":0},{"id":"2602042517","title":"Progyny Expects Q4 and Full-Year Results to Exceed Prior Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2602042517","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602042517?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:00","pubTimestamp":1768222835,"startTime":"0","endTime":"0","summary":"Progyny Inc. announced that it expects its financial results for the fourth quarter and full year ending December 31, 2025, to be slightly above the previously provided guidance. The company cited favorable member engagement during the fourth quarter as a key driver for this improved outlook. Revenue, net income, and Adjusted EBITDA are all anticipated to exceed the ranges shared in November, excluding any non-cash impacts related to the departure of the company's president, Michael Sturmer.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Progyny Inc. published the original content used to generate this news brief via GlobeNewswire  on January 12, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL5lXStb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","SG9999014013.SGD","LU2210149790.SGD","BK4585","SG9999014039.USD","IE00BGHQF748.EUR","BK4154","BK4112","IE00BKPKM429.USD","PGNY","SG9999014005.SGD","LU2210150020.SGD","IE00B3QW5Z07.USD","SG9999014021.USD","LU0314104364.USD","NDAQ","LU2095319765.USD","BK4588"],"gpt_icon":0},{"id":"2602751085","title":"Press Release: Progyny to Discuss Updated Financial Expectations at Upcoming JP Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2602751085","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602751085?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:00","pubTimestamp":1768222800,"startTime":"0","endTime":"0","summary":"NEW YORK, Jan. 12, 2026  -- Progyny, Inc.  , a global leader in women's health and family building solutions, today announced that the Company is participating in the 44th Annual JP Morgan Healthcare Conference, where it intends to discuss its updated expectations for the quarter and year ending December 31, 2025.\"As the fourth quarter progressed, we were pleased to see that member engagement has paced favorably as compared to the guidance we issued in November,\" said Pete Anevski, Progyny's Chief Executive Officer. \"Accordingly, we now expect our fourth quarter results for revenue, net income and Adjusted EBITDA to be slightly above the ranges that we provided in November, excluding any non-cash impacts to net income associated with the previously announced departure of Michael Sturmer as Progyny's president.\". This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ1G4Q59.USD","LU1989772840.SGD","LU1548497426.USD","LU0314104364.USD","LU1363072403.SGD","LU1162221912.USD","LU0158827948.USD","LU0320765646.SGD","LU0098860793.USD","BK4137","LU1791710400.SGD","LU0158827781.USD","IE00BKVL7J92.USD","BK4585","LU0267386448.USD","LU1244550221.USD","BK4581","HCSG","LU1244550577.SGD","PGNY","LU0795875086.SGD","LU1791710582.SGD","LABU","LU1732800096.USD","LU2089284900.SGD","XBI","BK4516","LU0528227936.USD","LU2357305700.SGD","LU1074936037.SGD","LU2023251221.USD","LU0795875169.SGD","LU2089283258.USD","LU2133065610.SGD","XLV","LU0106261372.USD","LU2028103732.USD","LU2271345857.HKD","LU0225283273.USD","BK4127","BK4588","LU1732799900.SGD","LU0029874061.USD","BK4504","LU0106831901.USD","BK4154","LU0882574139.USD","LU0128526141.USD","LU2347655156.SGD","LU1720051017.SGD"],"gpt_icon":0},{"id":"2602581224","title":"Assessing Progyny (PGNY) Valuation After Keybanc Upgrade And Strong Fertility Benefits Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2602581224","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602581224?lang=en_us&edition=fundamental","pubTime":"2026-01-10 14:20","pubTimestamp":1768026056,"startTime":"0","endTime":"0","summary":"Progyny (PGNY) is back in focus after a recent Keybanc upgrade, with the firm citing continued confidence in the fertility benefits provider, as solid year over year revenue and profit gains support investor interest.\nSee our latest analysis for Progyny.\nThe recent Keybanc upgrade and 52 week high come on top of a 90 day share price return of 34.28% and a 1 year total shareholder return of 43.87%, although the 3 and 5 year total shareholder returns remain negative. This suggests momentum has...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6034000-choice2-main-header/1585187286151","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6034000-choice2-main-header/1585187286151"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-pgny/progyny/news/assessing-progyny-pgny-valuation-after-keybanc-upgrade-and-s","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-pgny/progyny/news/assessing-progyny-pgny-valuation-after-keybanc-upgrade-and-s","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PGNY"],"gpt_icon":0},{"id":"2601398264","title":"Progyny Is Maintained at Overweight by Keybanc","url":"https://stock-news.laohu8.com/highlight/detail?id=2601398264","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601398264?lang=en_us&edition=fundamental","pubTime":"2026-01-08 22:43","pubTimestamp":1767883380,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PGNY/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 08, 2026 09:43 ET (14:43 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PGNY"],"gpt_icon":0},{"id":"2601637983","title":"KeyBanc Remains a Buy on Progyny (PGNY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2601637983","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601637983?lang=en_us&edition=fundamental","pubTime":"2026-01-08 19:16","pubTimestamp":1767870993,"startTime":"0","endTime":"0","summary":"In a report released today, Scott Schoenhaus from KeyBanc maintained a Buy rating on Progyny, with a price target of $32.00. Schoenhaus covers the ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/keybanc-remains-a-buy-on-progyny-pgny-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/keybanc-remains-a-buy-on-progyny-pgny-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4154","PGNY"],"gpt_icon":0},{"id":"2593103468","title":"Leadership Reshuffle Without a Successor Might Change The Case For Investing In Progyny (PGNY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2593103468","media":"Simply Wall St.","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593103468?lang=en_us&edition=fundamental","pubTime":"2025-12-22 09:15","pubTimestamp":1766366104,"startTime":"0","endTime":"0","summary":"Progyny, Inc. disclosed that its President, Michael Sturmer, will leave the company effective December 31, 2025, receiving severance under his existing 2021 employment agreement.\nThe company will not appoint a new President, instead relying on its recently expanded C-suite, covering commercial, technology, operations and product leadership, to absorb those responsibilities.\nWe’ll now explore how the decision to forgo a direct successor to the President role may influence Progyny’s investment...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6034000-choice2-main-header/1585187286151","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6034000-choice2-main-header/1585187286151"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-pgny/progyny/news/leadership-reshuffle-without-a-successor-might-change-the-ca","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-pgny/progyny/news/leadership-reshuffle-without-a-successor-might-change-the-ca","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PGNY","BK4154"],"gpt_icon":0},{"id":"2592990912","title":"Progyny Inc. Awards $250,000 Annual Advisory Fee to Outgoing President Under New Consulting Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2592990912","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592990912?lang=en_us&edition=fundamental","pubTime":"2025-12-17 21:01","pubTimestamp":1765976497,"startTime":"0","endTime":"0","summary":"Progyny Inc. has announced that President Michael Sturmer's employment will end effective December 31, 2025. In connection with his departure, Mr. Sturmer will receive severance payments and benefits according to his existing employment agreement. Additionally, he has entered into a consulting agreement with Progyny to serve as a non-employee consultant through December 31, 2026, for an annual advisory fee of $250,000. If Mr. Sturmer continues in this role through June 30, 2026, his vested stock options will remain exercisable beyond their original expiration date for a period proportional to his consulting service.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Progyny Inc. published the original content used to generate this news bri","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nNDL9Qr4Zk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4154","PGNY"],"gpt_icon":0},{"id":"2591872624","title":"Progyny CFO Mark S. Livingston Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2591872624","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591872624?lang=en_us&edition=fundamental","pubTime":"2025-12-16 05:13","pubTimestamp":1765833191,"startTime":"0","endTime":"0","summary":"Mark S. Livingston, Chief Financial Officer of Progyny Inc., reported a disposal of common shares of Progyny Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Progyny Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 15, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nNDL5dj6nW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Progyny CFO Mark S. Livingston Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4154","PGNY"],"gpt_icon":0},{"id":"2590328966","title":"Progyny Initiated at Overweight by Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2590328966","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590328966?lang=en_us&edition=fundamental","pubTime":"2025-12-10 00:23","pubTimestamp":1765297380,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PGNY/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 09, 2025 11:23 ET (16:23 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PGNY"],"gpt_icon":0},{"id":"2590365071","title":"Progyny Inc. EVP and General Counsel Allison Swartz Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2590365071","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590365071?lang=en_us&edition=fundamental","pubTime":"2025-12-09 05:23","pubTimestamp":1765229022,"startTime":"0","endTime":"0","summary":"Allison Swartz, EVP and General Counsel of Progyny Inc., reported a disposal of common shares of Progyny Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Progyny Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 08, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nNDL314XpG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Progyny Inc. EVP and General Counsel Allison Swartz Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4154","PGNY"],"gpt_icon":0},{"id":"2589842996","title":"Has Progyny’s 62.7% Surge Outrun Its Fundamentals in 2025?","url":"https://stock-news.laohu8.com/highlight/detail?id=2589842996","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589842996?lang=en_us&edition=fundamental","pubTime":"2025-12-06 13:19","pubTimestamp":1764998398,"startTime":"0","endTime":"0","summary":"Wondering if Progyny is still a smart buy after its big run, or if you have already missed the window? This breakdown will help you decide whether the current price really matches the company’s long term potential.\nDespite a choppy last week with the share price down 8.9%, Progyny is still up 27.2% over the last month, 35.5% year to date, and 62.7% over the past year, even though 3 and 5 year returns remain in the red.\nRecent gains have come as investors refocus on structural demand for...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6034000-choice2-main-header/1585187286151","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6034000-choice2-main-header/1585187286151"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-pgny/progyny/news/has-progynys-627-surge-outrun-its-fundamentals-in-2025","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-pgny/progyny/news/has-progynys-627-surge-outrun-its-fundamentals-in-2025","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4154","PGNY","DCF"],"gpt_icon":0},{"id":"2589426837","title":"Progyny CFO Mark S. Livingston Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2589426837","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589426837?lang=en_us&edition=fundamental","pubTime":"2025-12-05 05:18","pubTimestamp":1764883102,"startTime":"0","endTime":"0","summary":"Mark S. Livingston, Chief Financial Officer of Progyny Inc., reported a disposal of common shares of the company, according to a recent SEC filing. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Progyny Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 04, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251204:nNDL9sZdq5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Progyny CFO Mark S. Livingston Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PGNY","BK4154"],"gpt_icon":0},{"id":"2588667600","title":"Progyny EVP and General Counsel Allison Swartz Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2588667600","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588667600?lang=en_us&edition=fundamental","pubTime":"2025-12-03 05:16","pubTimestamp":1764710178,"startTime":"0","endTime":"0","summary":"Allison Swartz, Executive Vice President and General Counsel of Progyny Inc., reported a disposal of common shares of Progyny Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Progyny Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 02, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nNDL8Vrm3l:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Progyny EVP and General Counsel Allison Swartz Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4154","PGNY"],"gpt_icon":0},{"id":"2587795822","title":"A Fresh Look at Progyny (PGNY) Valuation Following the Stock’s Recent Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=2587795822","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2587795822?lang=en_us&edition=fundamental","pubTime":"2025-11-30 12:25","pubTimestamp":1764476752,"startTime":"0","endTime":"0","summary":"Progyny (PGNY) shares have shown considerable momentum lately, catching the eye of investors over the past month. The stock price has moved up, stirring curiosity about what is fueling the recent gains and whether the trend will hold.\nSee our latest analysis for Progyny.\nProgyny’s impressive 41% share price return over the past month has powered a strong comeback, building on momentum from earlier in the year. While short-term swings have been notable, the one-year total shareholder return of...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6034000-choice2-main-header/1585187286151","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6034000-choice2-main-header/1585187286151"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-pgny/progyny/news/a-fresh-look-at-progyny-pgny-valuation-following-the-stocks","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-pgny/progyny/news/a-fresh-look-at-progyny-pgny-valuation-following-the-stocks","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PGNY","BK4154"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.progyny.com","stockEarnings":[{"period":"1week","weight":-0.0535},{"period":"1month","weight":-0.0705},{"period":"3month","weight":0.2758},{"period":"6month","weight":0.0614},{"period":"1year","weight":0.014},{"period":"ytd","weight":-0.0705}],"compareEarnings":[{"period":"1week","weight":0.004},{"period":"1month","weight":0.0147},{"period":"3month","weight":0.0145},{"period":"6month","weight":0.113},{"period":"1year","weight":0.1437},{"period":"ytd","weight":0.0147}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.045948},{"month":2,"riseRate":0.166667,"avgChangeRate":-0.019098},{"month":3,"riseRate":0.5,"avgChangeRate":0.004077},{"month":4,"riseRate":0.666667,"avgChangeRate":0.004995},{"month":5,"riseRate":0.5,"avgChangeRate":-0.014121},{"month":6,"riseRate":0.666667,"avgChangeRate":0.002554},{"month":7,"riseRate":0.666667,"avgChangeRate":0.023707},{"month":8,"riseRate":0.666667,"avgChangeRate":0.02109},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.08524},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.033419},{"month":11,"riseRate":0.714286,"avgChangeRate":0.183609},{"month":12,"riseRate":0.571429,"avgChangeRate":0.032965}],"exchange":"NASDAQ","name":"Progyny","nameEN":"Progyny"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Progyny(PGNY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Progyny(PGNY) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Progyny,PGNY,Progyny股票,Progyny股票老虎,Progyny股票老虎国际,Progyny行情,Progyny股票行情,Progyny股价,Progyny股市,Progyny股票价格,Progyny股票交易,Progyny股票购买,Progyny股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Progyny(PGNY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Progyny(PGNY) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction